BDBM299662 (2R,4R)-2-(4-Aminobutyrylamino)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-[(3H-[1,2,3]triazole-4-carbonyl)amino]pentanoic Acid::US9593110, Example 40

SMILES OC(=O)[C@@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cnn[nH]1)N=[N+]=[N-]

InChI Key InChIKey=BBFUUWCGBAHVIO-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 299662   

TargetNeprilysin(Human)
Theravence Biopharma R&D Ip

US Patent
LigandPNGBDBM299662(US9593110, Example 40 | (2R,4R)-2-(4-Aminobutyryla...)
Affinity DataKi: <1nMAssay Description:Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp...More data for this Ligand-Target Pair
In DepthDetails
US Patent